James Mullen
Overview
James Mullen received an average of $5M in total compensation, including $257K in salary, at TuSimple Holdings from 2020 to 2022. James Mullen also received $7M at Editas Medicine in 2021.
Source: SEC filings on October 30, 2023, April 29, 2022, and April 26, 2022.
Related executives
We found 17 more executives who work or worked at TuSimple Holdings and Editas Medicine.
Cheng Lu
TuSimple Holdings
Chief Executive Officer
Patrick Dillon
TuSimple Holdings
Chief Financial Officer
Eric Tapia
TuSimple Holdings
Chief Financial Officer
Ersin Yumer
TuSimple Holdings
Chief Executive Officer
Xiaodi Hou
TuSimple Holdings
Chief Executive Officer
Mark Shearman
Editas Medicine
Chief Scientific Officer
Michelle Robertson
Editas Medicine
Chief Financial Officer
Bruce Eaton
Editas Medicine